Latest News and Press Releases

-- Total Q3 revenue up 80% over prior year ---- Cash on hand expected to fund operations through 2023 ---- Company to host call at 8:30am today -- NEWTOWN, Pa., Nov. 14, 2022 (GLOBE NEWSWIRE) --...

-- Fourth Center of Excellence added in multi-center, company-sponsored, open label observational interventional trial to evaluate impact of subjects’ adherence to PoNS® therapy for gait improvement...

NEWTOWN, Pa., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the...

NEWTOWN, Pa., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies (NASDAQ: HSDT) will showcase its innovative new Portable Neuromodulation Stimulator (PoNS®) at the 99th annual American...

NEWTOWN, Pa., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...

NEWTOWN, Pa., Oct. 13, 2022 (GLOBE NEWSWIRE) -- National Physical Therapy Month (NPTM) comes every October, but this one is particularly meaningful to Helius Medical Technologies (NASDAQ: HSDT):...

NEWTOWN, Pa., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...

NEWTOWN, Pa., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...

NEWTOWN, Pa., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...

-- Net proceeds from August 2022 financing and cash on hand expected to fund operations through 2023 ---- Company to host call at 4:30pm today -- NEWTOWN, Pa., Aug. 15, 2022 (GLOBE NEWSWIRE) --...